Liz Rockett is a venture investor for Kaiser Permanente Ventures, where she invests in healthcare IT, digital health and tech-enabled services in healthcare. Liz serves on the boards of Big Health and Chrono Therapeutics, as a board observer for Omada and MetricStream, and on the LP investment committee of Rock Health. Prior to KPV, Liz ran health impact investing for Imprint Capital, which was acquired by Goldman Sachs. Liz’s operating background is in product development and customer success at the Advisory Board Company (acquired by Optum), TriZetto, and Outcome (acquired by Quintiles). She completed undergrad at Princeton, and her MBA and MPH at UC Berkeley. Liz has a longstanding love of all things related to people strategy, team culture and career development. You can find her on Medium, Twitter, or around conferences.